Weekly Briefing for November 1 to 7, 2026

NOV 8, 20265 MIN

Description

The Food and Drug Administration (FDA) posted a class 2 recall on Nov. 4 of Intelerad's IntelePACS software over a cybersecurity vulnerability that could let an attacker alter or delete images. The PROCEM trial of preoperative contrast-enhanced mammography missed its primary end point, and the P4 trial found CT angiography guidance noninferior to intravascular ultrasound for coronary intervention. Read this week's roundup and its sources: https://physicianintheloop.org/specialties/radiology/2026-11-01/ Get this roundup by email, free The voices on this episode are generated by AI, and so is the script, from the week's specialty roundup at Physician in the Loop. Every fact in the roundup links to its source.